Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults,The New England Journal of Medicine

当前位置： X-MOL 学术 › N. Engl. J. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2017-09-27 , DOI: 10.1056/nejmoa1707572
D. James Cooper ₁ , Zoe K. McQuilten ₁ , Alistair Nichol ₁ , Bridget Ady ₁ , Cécile Aubron ₁ , Michael Bailey ₁ , Rinaldo Bellomo ₁ , Dashiell Gantner ₁ , David O. Irving ₁ , Kirsi-Maija Kaukonen ₁ , Colin McArthur ₁ , Lynne Murray ₁ , Ville Pettilä ₁ , Craig French ₁

Affiliation

The age of transfused red cells did not affect 90-day mortality among critically ill adults. (Funded by the Australian National Health and Medical Research Council and others; TRANSFUSE Australian and New Zealand Clinical Trials Registry number, ACTRN12612000453886; ClinicalTrials.gov number, NCT01638416.)

中文翻译：

危重成年人中用于输血和结局的红细胞年龄

在危重成年人中，输血红细胞的年龄不会影响90天死亡率。（由澳大利亚国家卫生与医学研究委员会及其他机构资助； TRANSFUSE澳大利亚和新西兰临床试验注册号为ACTRN12612000453886； ClinicalTrials.gov号为NCT01638416。）

更新日期：2017-11-09

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文